The Association of Community Cancer Centers, in collaboration with AstraZeneca, Merck, and partner organizations: the Association for Molecular Pathology, the National Society of Genetic Counselors, and the Society of Gynecologic Oncology, has launched the Barriers to Quality Care in Ovarian Cancer project.
To access this subscriber-only content please log in or renew your subscription.
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe